Zimmer Biomet, Medtronic, DePuy Synthes & more: 16 key notes

Here are 16 key notes on orthopedic and spine device companies over the past week.

Advertisement

Zimmer Biomet plans to acquire majority stake in MedTech, a France-based company focused on the ROSA Robotic System for brain and spine surgery.

 

Zimmer Biomet and Indo UK Institutes of Health announced plans for a multi-year collaboration.

 

MedTech reported a 73 percent increase in revenue for the full year 2016 over $7.2 million in 2015.

 

Medtronic received the first-ever FDA clearance for cement-augmented pedicle screws in the CD Horizon Fenestrated Screws.

 

The FDA cleared Medtronic’s Prestige LP Cervical Disc for two-level applications.

 

Medtronic expanded its oblique lateral interbody fusion platform with its new Pivox Oblique Lateral Spinal System with Lateral Plate for OLIF25 and Divergence-L Anterior/Oblique Lumbar Fusion System for OLIF51.

 

Medtronic announced its goal is to generate $40 billion in free cash flow over the next five years, with half returned to shareholders as dividends and buybacks.

 

Johnson & Johnson reported DePuy Synthes’ orthopedics sales worldwide was $2.3 billion in the second quarter of 2016.

 

Life Spine reported its revenue increased 50 percent in the second quarter of 2016, compared to the same period in 2015.

 

Arthrex is expanding to create 560 jobs at its corporate campus in Naples, Fla.

 

InVivo Therapeutics added Ben Taub Hospital in Houston as a clinical site for the INSPIRE study.

 

Spineart’s new JULIET Ti lumbar interbody systems received the CE Mark.

 

IlluminOss Medical completed enrollment in its first U.S. clinical trial for its IlluminOss System.

 

Data from two new clinical studies on the Mazor robotic technology were presented at the International Meeting on Advanced Spine Techniques in Washington, DC.

 

A new multicenter retrospective study with a prospective evaluation of SI-BONE’s iFuse system shows how minimally invasive sacroiliac joint surgery can impact the appropriately-selected patients.

 

DePuy Synthes and Stryker lead the Australian bone graft substitutes market.

 

More articles on devices:
Medtronic stock receives target price of $87.83: 3 points
InVivo Therapeutics adds Ben Taub Hospital as INSPIRE study site: 4 things to know
Zimmer Biomet jumps into robotics with MedTech acquisition: 5 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Since March 25, there have been two key developments in lawsuits involving spine medtech companies. 1. The U.S. Court of…

  • The highest-paid CFOs at spine and orthopedic medtech companies saw total compensation reaching in the mid-single digits and beyond. Here…

Advertisement

Comments are closed.